boehringer glp 1 Boehringer's GLP-1 dual agonist survodutide shines in phase III trial | News Boehringer, Zealand's GLP-1 MASH Data

This real-world study is one of the first to assess CV, metabolic, and renal outcomes associated with newer generation GLP-1RAs (including dual GIP/GLP-1RA) in combination with SGLT2i

For broader wellness and monitoring, Primary Concierge Services can support ongoing care

Support Gut Health A Vegan Probiotic Blend (400B CFU/g) including Bifidobacterium lactis and Akkermansia muciniphila promotes digestive balance, nutrient absorption, and metabolic wellness

Hydration Adequate water intake is non-negotiable, especially if you are experiencing diarrhea

All medications remain subject to the same quality standards as traditional pharmacy dispensing

doi: 10.3389/fmed.2025.1633447 Received 22 May 2025 Accepted 11 August 2025 Published 29 August 2025 Volume 12 - 2025 Edited by Zili Xie, Icahn School of Medicine at Mount Sinai, United States Reviewed by Nina Fuller-Shavel, Synthesis Clinic, United Kingdom Ali Mussa, Omdurman Islamic University, Sudan Xiaoqing Cathy Cheng, Washington University in St